MKS (NASDAQ:MKSI) Releases Q4 2025 Earnings Guidance

MKS (NASDAQ:MKSI) updated its fourth quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of 2.270- for the period, compared to the consensus EPS estimate of 2.280. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $994.1 million.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on MKSI. The Goldman Sachs Group increased their price target on MKS from $92.00 to $125.00 and gave the stock a “sell” rating in a report on Thursday, October 9th. Benchmark raised their target price on shares of MKS from $135.00 to $180.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of MKS in a report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $175.00 price objective on shares of MKS and gave the company a “buy” rating in a research report on Friday, October 31st. Finally, Cantor Fitzgerald increased their target price on MKS from $200.00 to $300.00 and gave the stock an “overweight” rating in a report on Tuesday. Nine equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, MKS has a consensus rating of “Moderate Buy” and an average target price of $198.27.

MKS Stock Up 4.8%

Shares of NASDAQ:MKSI traded up $10.07 during trading on Wednesday, hitting $220.73. 1,942,571 shares of the company were exchanged, compared to its average volume of 731,273. The stock has a market cap of $14.83 billion, a price-to-earnings ratio of 53.58, a P/E/G ratio of 1.94 and a beta of 1.92. The company has a current ratio of 2.86, a quick ratio of 1.81 and a debt-to-equity ratio of 1.64. MKS has a fifty-two week low of $54.84 and a fifty-two week high of $221.07. The firm has a fifty day moving average price of $166.29 and a two-hundred day moving average price of $134.80.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.13. The firm had revenue of $988.00 million for the quarter, compared to analyst estimates of $963.87 million. MKS had a net margin of 7.25% and a return on equity of 20.80%. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.72 earnings per share. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, research analysts anticipate that MKS will post 6.94 earnings per share for the current fiscal year.

MKS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 24th were paid a $0.22 dividend. The ex-dividend date was Monday, November 24th. This represents a $0.88 annualized dividend and a yield of 0.4%. MKS’s dividend payout ratio is currently 21.36%.

Insider Activity at MKS

In related news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total transaction of $47,643.00. Following the transaction, the director directly owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. The trade was a 1.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On MKS

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of MKS by 3.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after purchasing an additional 9,170 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of MKS by 63.4% in the second quarter. EverSource Wealth Advisors LLC now owns 838 shares of the scientific and technical instruments company’s stock worth $83,000 after acquiring an additional 325 shares during the last quarter. First Trust Advisors LP lifted its stake in MKS by 3,545.6% in the 2nd quarter. First Trust Advisors LP now owns 141,267 shares of the scientific and technical instruments company’s stock valued at $14,036,000 after purchasing an additional 137,392 shares during the last quarter. Cerity Partners LLC acquired a new stake in shares of MKS during the 2nd quarter valued at $1,676,000. Finally, AXA S.A. boosted its stake in shares of MKS by 22.8% during the second quarter. AXA S.A. now owns 29,253 shares of the scientific and technical instruments company’s stock valued at $2,907,000 after purchasing an additional 5,430 shares in the last quarter. 99.79% of the stock is owned by institutional investors and hedge funds.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.